|
Treatment for Anxiety in Children Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Treatment for Anxiety in Children conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Treatment for Anxiety in Children Clinical research trials and Treatment for Anxiety in Children medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Treatment for Anxiety in Children. Treatment for Anxiety in Children Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Treatment for Anxiety in Children clinical trial. Subjects often receive the most expert healthcare possible for their Treatment for Anxiety in Children condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treatment for Anxiety in Children  Treatment for Anxiety in Children
Treatment for Anxiety in Children
For Condition: Obsessive-Compulsive Disorder,Anxiety Disorders,Generalized Anxiety Disorder,Social Phobia,Separation Anxiety
Status: Completed
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to see if it is effective to treat children with anxiety disorders with fluvoxamine. Fluvoxamine has been successfully used to treat obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD, such as generalized anxiety disorder, social phobia, or separation anxiety, are very common in youth and are not always responsive to behavioral therapies alone. These disorders may respond to fluvoxamine. A child will be evaluated for 3 weeks before he/she is assigned randomly (like tossing a coin) to receive either fluvoxamine or an inactive placebo for 8 weeks. After this double-blind phase (neither the child/parents nor the doctor know which treatment is being given), the child will have the option of continuing treatment during a 4-month open-label extension period (both the child/parents and the doctor know which the child is receiving). A child may be eligible for this study if he/she: Is 6 to 17 years old and has been diagnosed with an anxiety disorder (i.e., generalized anxiety disorder, social phobia, or separation anxiety).
Details: To evaluate fluvoxamine in the treatment of children and adolescents with anxiety disorders. Fluvoxamine is a serotonin reuptake inhibitor that is FDA-approved for the treatment of obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD are very common in youth and are not always responsive to psychosocial therapies. Fluvoxamine is an alternative treatment. After a 3-week period of evaluation, patients meeting study entry criteria are randomized to receive either fluvoxamine or placebo for 8 weeks. After this double-blind phase, patients can enter a 4-month open-label extension.
Eligibility:
Study Type: Interventional, Treatment, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 6 Years/17 Years
Genders: Both
Protocol Entry Criteria: - Patients must have: DSM -IV diagnosis of generalized anxiety disorder, social phobia, or separation anxiety.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
LaurenceGreenhill, Principal Investigator,
Additional Information:
Study ID Numbers: MH60005; MH60016
Study Start Date: October 1996
Record last reviewed: April 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000389
Other Generalized Anxiety Disorder Studies:
1. Treatment for Anxiety in Children
Related Studies:
Other Generalized Anxiety Disorder Clinical Trials
Other Clinical Trials
Other Clinical Trials
Treatment for Anxiety in Children
|
|
|
|
|
|
|
|
